Benutzerspezifische Werkzeuge

Kopf-Hals-Tumoren

HNSCC: AstraZeneca D5660C00004

A Phase 1b/2, Open-Label, Multicentre Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumour Activity of MEDI4736 in Combination With AZD9150 or AZD5069 in Patients With Advanced Solid Malignancies and Subsequently Comparing AZD9150 and AZD5069 ...Mehr…